Isolated Thoracic Perfusion (ITP-F) for MPM

• Status: Completed
• Trial end date: 2015-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This is an observational study of isolated thoracic perfusion with subsequent hemofiltration to lower the concentration of the cytotoxic drugs as a locoregional therapeutic strategy in malignant pleural mesothelioma.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medias Klinikum for Surgical Oncology
• Treatments: Mitoxantrone

Criteria

Inclusion Criteria:

• History of pre-treated Malignant Pleural Mesothelioma, Progress after Staging

Exclusion Criteria:

• Drug abuse, distant metastases, no bone marrow function